If over-the-counter laxatives provide no relief after one week of appropriate use, or if you find yourself requiring increasing doses or multiple laxative types, medical review is advisable
XRCC1 - Strategies for coordinating and assembling a versatile DNA damage response
J Pharmaceutical Sciences 104(9): 3170-3182
A recent study from Cornell University finds that households with at least one GLP-1 user reduced grocery spending by 5.5 percent within six months of adoptionequivalent to approximately $416 less per household per year.[77] This decline was especially pronounced among higher-income households and was concentrated in specific product categories, particularly ultra-processed foods such as snacks, sweets, and baked goods.[78] With over 40 percent of American adults living with obesity, even a conservative estimate of 10 percent uptake of GLP-1 therapies within this population would amount to approximately 10 million users
Conditions like these are identified through clinical evaluation by a specialist, not by a consumer wellness report
The introduction of Mounjaro (Tirzepatide) has been a game changer
